Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol Dose Escalation in Primary Lymphedema
NCT02595996Phase 2Terminated
- Sponsor
- Columbia University
- Start
- Jun 2017
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in primary lymphedema, sponsored by Columbia University. Started Jun 2017; status: terminated.
02
Drugs
propranolol
03
Conditions
primary lymphedema
Beyond the preview
Go deeper on NCT02595996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02595996.